Anaplastic thyroid carcinoma: Current diagnosis and treatment

Annals of Oncology

Volumn 11, Issue 9, 2000, Pages 1083-1089

  Giuffrida, D ^a,b   Gharib, H ^a  

^a MAYO CLINIC   (United States)

^b GARIBALDI HOSPITAL   (Italy)

Author keywords

Diagnosis; Neoplasm; Thyroid; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ANAPLASTIC CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYROID CARCINOMA; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE OF ONSET; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOPSY, NEEDLE; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; PACLITAXEL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0033783980     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008322002520     Document Type: Review

References (77)

1. The epidemiology of thyroid carcinoma
2. Thyroid cancers of follicular cell origin
3. Natural history, treatment, and course of papillary thyroid carcinoma
4. The results of various modalities of treatment of well-differentiated thyroid carcinomas: A retrospective review of 1599 patients
5. Prognosis in thyroid carcinoma
6. Anaplastic thyroid carcinoma: Behavior, biology, and therapeutic approaches
7. Anaplastic carcinoma of the thyroid: A review of 84 cases of spindle and giant-cell carcinoma of the thyroid
8. Prognosis of undifferentiated carcinoma and lymphoma of the thyroid
9. Anaplastic spindle-cell and giant-cell tumors of the thyroid gland
10. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program
11. The frequency of cold thyroid nodules and thyroid malignancies in patients from an iodine-deficient area
12. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma
13. Undifferentiated and poorly differentiated carcinoma
14. Undifferentiated or anaplastic carcinoma of the thyroid
15. Anaplastic carcinoma following well-differentiated thyroid cancer: Etiological considerations
16. Anaplastic transformation of metastatic follicular carcinoma of the thyroid
17. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas
18. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
19. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid
20. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein
21. CD97: A dedifferentiation marker in human thyroid carcinomas
22. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
23. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma
24. Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1
25. Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines
26. Anaplastic thyroid carcinoma producing the granulocyte colony stimulating factor (G-CSF): Report of a case
27. Anaplastic thyroid carcinoma with prominent cardiac metastasis, accompanied by a marked leukocytosis with a neutrophilia and high GM-CSF level in serum
28. Anaplastic thyroid carcinoma. A study of 70 cases
29. Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer
30. Co-existent anaplastic and well differentiated thyroid carcinomas: A nuclear DNA study
31. Spindle cell squamous carcinoma of the thyroid: An unusual anaplastic tumor associated with tall cell papillary cancer
32. Anaplastic thyroid cancer twelve years after radioiodine therapy
33. Transformation of low-grade papillary carcinoma of the thyroid to an anaplastic carcinoma after treatment with radioiodine
34. Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant-cell lymphoma
35. Uncommon types of thyroid cancer
36. Anaplastic thyroid carcinoma: Cytomorphology and clinical implications of fine-needle aspiration
37. Anaplastic thyroid carcinoma. Immunocytochemical study of 32 cases
38. Anaplastic thyroid carcinoma. A clinical, histologic, and immunohistochemical study
39. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases
40. Immunohistochemical analysis of small-cell tumors of the thyroid gland: An Eastern Cooperative Oncology Group study
41. Immunohistochemical study of thyroglobulin in thyroid carcinomas with monoclonal antibodies
42. Immunocytochemistry of anaplastic carcinoma of thyroid gland
43. Anaplastic thyroid tumors. Immunohistology
44. A presentation of anaplastic carcinoma of the thyroid with symptomatic intra-abdominal metastases
45. CT evaluation of anaplastic thyroid carcinoma
46. Anaplastic carcinoma of the thyroid: A clinicopathologic study of 82 cases
47. Anaplastic carcinoma of the thyroid
48. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association
49. Current management of thyroid cancer
50. Anaplastic giant-cell carcinoma of the thyroid. A study of treatment and prognosis
51. Anaplastic carcinoma of the thyroid: A 24-year experience
52. Anaplastic thyroid carcinoma: Ninety-one patients treated by surgery and radiotherapy
53. Treatment of 37 patients with anaplastic carcinoma of the thyroid
54. Anaplastic carcinoma of the thyroid gland treated by radiation therapy
55. Anaplastic thyroid carcinoma: A new approach
56. Myelopathy following hyperfractionated accelerated radiotherapy for anaplastic thyroid carcinoma
57. Anaplastic thyroid carcinoma: Risk factors and outcome
58. Phase II evaluation of high-dose accelerated radiotherapy for anaplastic thyroid carcinoma
59. Treatment of anaplastic giant and spindle-cell carcinoma of the thyroid gland with combination adriamycin and radiation therapy. A new approach
60. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy
61. Anaplastic thyroid carcinoma. Doxorubicin, hyperfractionated radiotherapy and surgery
62. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma: Report on two protocols
63. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma
64. Treatment of refractory thyroid cancer with adriamycin
65. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma
66. Chemotherapy of thyroid carcinoma
67. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer
68. Intensive chemotherapy for anaplastic thyroid carcinoma: Combination of cisplatin doxorubicin, etoposide and peplomycin with granulocyte colony-stimulating factor support
69. Results of combined modality treatment in poorly differentiated and anaplastic thyroid carcinoma
70. Thyroid cancer: Different outcomes to chemotherapy according to tumour histology
71. Undifferentiated thyroid carcinoma and unusual thyroid malignancies
72. Multimodality treatment in anaplastic giant-cell thyroid carcinoma
73. Multimodal therapy in anaplastic giant cell thyroid carcinoma
74. Anaplastic thyroid carcinoma: Retrospective analysis of 34 patients treated with external radiotherapy (R), chemotherapy (C) or both (R + C)
75. Combination therapy for anaplastic giant-cell thyroid carcinoma
76. Anaplastic carcinoma of the thyroid
77. Antineoplastic activity of Taxol against human anaplastic thyroid carcinoma cell lines in vitro and in vivo